Cargando…

Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome

BACKGROUND: Down syndrome (DS) is a complex disorder caused by the trisomy of either the entire, or a critical region of chromosome 21 (21q22.1-22.3). Despite representing the most common cause of mental retardation, the molecular bases of the syndrome are still largely unknown. METHODS: To better u...

Descripción completa

Detalles Bibliográficos
Autores principales: Granese, Barbara, Scala, Iris, Spatuzza, Carmen, Valentino, Anna, Coletta, Marcella, Vacca, Rosa Anna, De Luca, Pasquale, Andria, Generoso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717290/
https://www.ncbi.nlm.nih.gov/pubmed/23830204
http://dx.doi.org/10.1186/1755-8794-6-24
_version_ 1782277682712543232
author Granese, Barbara
Scala, Iris
Spatuzza, Carmen
Valentino, Anna
Coletta, Marcella
Vacca, Rosa Anna
De Luca, Pasquale
Andria, Generoso
author_facet Granese, Barbara
Scala, Iris
Spatuzza, Carmen
Valentino, Anna
Coletta, Marcella
Vacca, Rosa Anna
De Luca, Pasquale
Andria, Generoso
author_sort Granese, Barbara
collection PubMed
description BACKGROUND: Down syndrome (DS) is a complex disorder caused by the trisomy of either the entire, or a critical region of chromosome 21 (21q22.1-22.3). Despite representing the most common cause of mental retardation, the molecular bases of the syndrome are still largely unknown. METHODS: To better understand the pathogenesis of DS, we analyzed the genome-wide transcription profiles of lymphoblastoid cell lines (LCLs) from six DS and six euploid individuals and investigated differential gene expression and pathway deregulation associated with trisomy 21. Connectivity map and PASS-assisted exploration were used to identify compounds whose molecular signatures counteracted those of DS lymphoblasts and to predict their therapeutic potential. An experimental validation in DS LCLs and fetal fibroblasts was performed for the most deregulated GO categories, i.e. the ubiquitin mediated proteolysis and the NF-kB cascade. RESULTS: We show, for the first time, that the level of protein ubiquitination is reduced in human DS cell lines and that proteasome activity is increased in both basal conditions and oxidative microenvironment. We also provide the first evidence that NF-kB transcription levels, a paradigm of gene expression control by ubiquitin-mediated degradation, is impaired in DS due to reduced IkB-alfa ubiquitination, increased NF-kB inhibitor (IkB-alfa) and reduced p65 nuclear fraction. Finally, the DSCR1/DYRK1A/NFAT genes were analysed. In human DS LCLs, we confirmed the presence of increased protein levels of DSCR1 and DYRK1A, and showed that the levels of the transcription factor NFATc2 were decreased in DS along with a reduction of its nuclear translocation upon induction of calcium fluxes. CONCLUSIONS: The present work offers new perspectives to better understand the pathogenesis of DS and suggests a rationale for innovative approaches to treat some pathological conditions associated to DS.
format Online
Article
Text
id pubmed-3717290
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37172902013-07-21 Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome Granese, Barbara Scala, Iris Spatuzza, Carmen Valentino, Anna Coletta, Marcella Vacca, Rosa Anna De Luca, Pasquale Andria, Generoso BMC Med Genomics Research Article BACKGROUND: Down syndrome (DS) is a complex disorder caused by the trisomy of either the entire, or a critical region of chromosome 21 (21q22.1-22.3). Despite representing the most common cause of mental retardation, the molecular bases of the syndrome are still largely unknown. METHODS: To better understand the pathogenesis of DS, we analyzed the genome-wide transcription profiles of lymphoblastoid cell lines (LCLs) from six DS and six euploid individuals and investigated differential gene expression and pathway deregulation associated with trisomy 21. Connectivity map and PASS-assisted exploration were used to identify compounds whose molecular signatures counteracted those of DS lymphoblasts and to predict their therapeutic potential. An experimental validation in DS LCLs and fetal fibroblasts was performed for the most deregulated GO categories, i.e. the ubiquitin mediated proteolysis and the NF-kB cascade. RESULTS: We show, for the first time, that the level of protein ubiquitination is reduced in human DS cell lines and that proteasome activity is increased in both basal conditions and oxidative microenvironment. We also provide the first evidence that NF-kB transcription levels, a paradigm of gene expression control by ubiquitin-mediated degradation, is impaired in DS due to reduced IkB-alfa ubiquitination, increased NF-kB inhibitor (IkB-alfa) and reduced p65 nuclear fraction. Finally, the DSCR1/DYRK1A/NFAT genes were analysed. In human DS LCLs, we confirmed the presence of increased protein levels of DSCR1 and DYRK1A, and showed that the levels of the transcription factor NFATc2 were decreased in DS along with a reduction of its nuclear translocation upon induction of calcium fluxes. CONCLUSIONS: The present work offers new perspectives to better understand the pathogenesis of DS and suggests a rationale for innovative approaches to treat some pathological conditions associated to DS. BioMed Central 2013-07-05 /pmc/articles/PMC3717290/ /pubmed/23830204 http://dx.doi.org/10.1186/1755-8794-6-24 Text en Copyright © 2013 Granese et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Granese, Barbara
Scala, Iris
Spatuzza, Carmen
Valentino, Anna
Coletta, Marcella
Vacca, Rosa Anna
De Luca, Pasquale
Andria, Generoso
Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome
title Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome
title_full Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome
title_fullStr Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome
title_full_unstemmed Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome
title_short Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome
title_sort validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and nf-kb in the pathogenesis of down syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717290/
https://www.ncbi.nlm.nih.gov/pubmed/23830204
http://dx.doi.org/10.1186/1755-8794-6-24
work_keys_str_mv AT granesebarbara validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome
AT scalairis validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome
AT spatuzzacarmen validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome
AT valentinoanna validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome
AT colettamarcella validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome
AT vaccarosaanna validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome
AT delucapasquale validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome
AT andriageneroso validationofmicroarraydatainhumanlymphoblastsshowsaroleoftheubiquitinproteasomesystemandnfkbinthepathogenesisofdownsyndrome